CDE Catalog

***Please contact the NINDS CDE Team (NINDSCDE@emmes.com) if you encounter any search difficulties.***

The CDE Catalog is a directory of the available NINDS CDEs. Users can search the Catalog to isolate a subset of the CDEs (e.g., all stroke-specific CDEs, etc.), and to view and download details about the CDEs.

Select any filter below to search the CDE Catalog.

For best results, clear form between searches. In addition, when specifying NeuroRehab, Sport-Related Concussion (SRC) or Traumatic Brain Injury (TBI) as the Disease, please select a Subdisease as well.

NeuroRehab Comprehensive includes all NeuroRehab CDE recommendations. NeuroRehab General includes all NeuroRehab CDE recommendations that are not disease specific. All other NeuroRehab Subdiseases include recommendations specific to existing NINDS CDE project disorders.

Choose your Time Frame for your SRC study (Acute (time of injury until 72 hours), Subacute (after 72 hours to 3 months), and Persistent/Chronic (3 months and greater post-concussion) or Comprehensive if your study falls across the study time frames.

Choose your type of TBI study (Acute Hospitalized, Concussion/Mild TBI, Moderate/Severe TBI: Rehabilitation, or Epidemiology) or Comprehensive if your study falls outside of the study types or incorporates aspects of more than one type of study.

Search Form

Displaying 1326 - 1350 of 1547
Operations
Selected 25 rows in this page.  
The search results below can be downloaded by clicking the checkboxes on the far left side of the table. Select the header checkbox to select all CDEs listed on the first page. Then choose CDE Detailed Report from the Choose an operation dropdown menu.
CDE ID CDE Name Definition Classification CRF Name Copyrighted or trademarked Disease Name Subdisease Name
C58951 Anticoagulant agent stroke discharge prescribe other text

The free-text field related to 'Anticoagulant agent stroke discharge prescribe type', specifying other text

Supplemental-Highly Recommended Antithrombotics and Risk Factor Controlling Medications Stroke Stroke
C58952 Antiplatelet agent stroke discharge prescribe type

Type(s) of antiplatelet agents prescribed at discharge following stroke

Supplemental-Highly Recommended Antithrombotics and Risk Factor Controlling Medications Stroke Stroke
C58953 Antiplatelet agent stroke discharge prescribe other text

The free-text field related to 'Antiplatelet agent stroke discharge prescribe type', specifying other text

Supplemental-Highly Recommended Antithrombotics and Risk Factor Controlling Medications Stroke Stroke
C58954 Antihypertensive agent stroke discharge prescribe type

Type(s) of antihypertensive agents prescribed at discharge following stroke

Supplemental-Highly Recommended Antithrombotics and Risk Factor Controlling Medications Stroke Stroke
C58955 Antihypertensive agent stroke discharge prescribe other text

The free-text field related to 'Antihypertensive agent stroke discharge prescribe type', specifying other text

Supplemental-Highly Recommended Antithrombotics and Risk Factor Controlling Medications Stroke Stroke
C58956 Anti diabetic agent stroke discharge prescribe type

Type(s) of anti-diabetic agents prescribed at discharge following stroke

Supplemental-Highly Recommended Antithrombotics and Risk Factor Controlling Medications Stroke Stroke
C58957 Anti diabetic agent stroke discharge prescribe other text

The free-text field related to 'Anti diabetic agent stroke discharge prescribe type', specifying other text

Supplemental-Highly Recommended Antithrombotics and Risk Factor Controlling Medications Stroke Stroke
C58958 Lipid lower agent stroke discharge prescribe type

Type(s) of lipid lowering agents prescribed at discharge following stroke

Supplemental-Highly Recommended Antithrombotics and Risk Factor Controlling Medications Stroke Stroke
C58959 Lipid lower agent stroke discharge prescribe other text

The free-text field related to 'Lipid lower agent stroke discharge prescribe type', specifying other text

Supplemental-Highly Recommended Antithrombotics and Risk Factor Controlling Medications Stroke Stroke
C58960 Antithrombotic therapy not prescribed serious side effect text

The free-text field related to 'Antithrombotic therapy not prescribed reason', specifying serious side effect to medication text

Supplemental Antithrombotics and Risk Factor Controlling Medications Stroke Stroke
C12207 Gastrointestinal therapy take nutrition supplement indicator

Indicator whether the participant/subject is taking nutritional supplements

Exploratory Prior and Concomitant Medications Stroke Stroke
C12208 Gastrointestinal therapy nutrition supplement type

Type(s) of nutritional supplement(s) being taken by the participant/subject

Exploratory Prior and Concomitant Medications Stroke Stroke
C18827 Gastrointestinal therapy nutrition supplement other text

The free-text field related to 'Gastrointestinal therapy nutrition supplement type' specifying other text. Type(s) of nutritional supplement(s) being taken by the participant/subject

Exploratory Prior and Concomitant Medications Stroke Stroke
C54985 Stimulant current former use type

Type of stimulant formerly or currently taken by the subject/participant

Supplemental Prior and Concomitant Medications Stroke Stroke
C54986 Stimulant current former use other text

The free-text field related to 'Stimulant current former use type' specifying other text

Supplemental Prior and Concomitant Medications Stroke Stroke
C54987 Stimulant current former use duration

Duration in months for which the subject/participant took or has taken the selected former or current stimulant

Supplemental Prior and Concomitant Medications Stroke Stroke
C54988 Stimulant current former use age start value

Age in years at which the subject/participant began taking the selected former or current stimulant

Supplemental Prior and Concomitant Medications Stroke Stroke
C54989 Stimulant former use age end value

Age in years at which the subject/participant stopped taking the selected former stimulant

Supplemental Prior and Concomitant Medications Stroke Stroke
C54990 Cocaine expose year prior unruptured intracranial aneurysm presentation indicator

Indicator of whether the subject/participant was exposed to cocaine in the year prior to clinical presentation of unruptured intracranial aneurysm (UIA)

Supplemental Prior and Concomitant Medications Stroke Stroke
C54991 Cocaine use duration

Duration in months for which the subject/participant took or has taken cocaine

Supplemental Prior and Concomitant Medications Stroke Stroke
C54992 Cocaine exposure age start value

Age in years at which the subject/participant began exposure to cocaine

Supplemental Prior and Concomitant Medications Stroke Stroke
C54993 Cocaine exposure age end value

Age in years at which the subject/participant's exposure to cocaine ended

Exploratory Prior and Concomitant Medications Stroke Stroke
C54994 Potency enhancing drug current former use type

Type of potency-enhancing drug formerly or currently taken by the subject/participant

Exploratory Prior and Concomitant Medications Stroke Stroke
C54995 Potency enhancing drug current former use duration

Duration in months for which the subject/participant took or has taken the specified potency-enhancing drug

Exploratory Prior and Concomitant Medications Stroke Stroke
C54996 Potency enhancing drug current former use age start value

Age in years at which the subject/participant began taking the specified former or current potency-enhancing drug

Exploratory Prior and Concomitant Medications Stroke Stroke
Displaying 1326 - 1350 of 1547

The NINDS CDE Team does not post proprietary instruments/scales recommended by the CDE Working Groups on this website. This includes, but is not limited to, copyrighted or trademarked instruments/scales. Information about recommended instruments can be found in the Notice of Copyright (NOC) documents under ‘CRF Module/Guideline’ on each disorder’s data standards page. For any questions regarding these instruments/scales please contact the corresponding owner/author. The NINDS CDE Team is not responsible for the availability or content of these external sites, nor does the NINDS CDE Team endorse, warrant or guarantee the products, services or information described or offered at these other internet sites.